Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.
Catalyx has announced the appointment of Mario L. Rocci, Jr., Ph.D., as its new chief executive officer, marking a pivotal step in the company’s strategic growth. Dr. Rocci, ...